Good article on Bloomberg today around big pharma/biotech buyouts and takeovers;
https://www.bloomberg.com/opinion/articles/2019-12-16/amarin-fish-oil-heart-drug-good-news-is-already-priced-in-stock?srnd=premium-asia
Relates to a bio-pharmaceutical company (Amarin) that's managed to patent a fish oil supplement (Vascepa) in pill form as a heart attack and stroke preventative.
Interesting points around restricted FDA approval, and a comment that insurance reimbursal wasn't assured, despite the low cost, because of the numbers of people likely to be taking it.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-380
-
- There are more pages in this discussion • 3,903 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
30.5¢ | 30.5¢ | 29.5¢ | $86.19K | 286.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 70151 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 70151 | 0.295 |
5 | 22897 | 0.290 |
3 | 38508 | 0.285 |
2 | 100000 | 0.280 |
5 | 42556 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18600 | 1 |
0.315 | 52964 | 5 |
0.320 | 70187 | 4 |
0.325 | 48316 | 3 |
0.330 | 56660 | 4 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |